Frank Andersohn
Impact in
-
- Pituitary Gland Disorders and Treatments
- Growth Hormone and Insulin-like Growth Factors
- Toxicology top 2%
Papers in
- Co-authors
- Edeltraut Garbe (33 shared papers)Samy Suissa (5 shared papers)R Schade (5 shared papers)Wilhelm Haverkamp (2 shared papers)Jochen Walker (5 shared papers)Elisabeth Bronder (12 shared papers)Andreas Klimpel (12 shared papers)Stefan N. Willich (8 shared papers)
- Journals
- European Journal of Clinical Pharmacology (5 papers)Pharmacoepidemiology and Drug Safety (5 papers)Annals of Internal Medicine (2 papers)American Journal of Psychiatry (2 papers)Clinical Research in Cardiology (2 papers)
- Partner nations
- GermanyUnited StatesCanada
In The Last Decade
Frank Andersohn
60 papers receiving 2.6k citations
Frank Andersohn's Hit Papers
Peers
Comparison fields: 5 of 120
- Endocrinology, Diabetes and Metabolism 418
- Toxicology 73
- Pharmacology 322
- Psychiatry and Mental health 251
- Neurology 209
Countries citing papers authored by Frank Andersohn
This map shows the geographic impact of Frank Andersohn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank Andersohn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank Andersohn more than expected).
Fields of papers citing papers by Frank Andersohn
This network shows the impact of papers produced by Frank Andersohn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank Andersohn. The network helps show where Frank Andersohn may publish in the future.
Co-authors
The 25 scholars most cited alongside Frank Andersohn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 61 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Dopamine Agonists and the Risk of Cardiac-Valve Regurgitation Hit paper breakdown → | 2007 | 552 |
| 2 | 2007 | 342 | |
| 3 | 2009 | 223 | |
| 4 | 2015 | 159 | |
| 5 | 2006 | 143 | |
| 6 | 2010 | 106 | |
| 7 | 2006 | 87 | |
| 8 | 2011 | 81 | |
| 9 | 2009 | 75 | |
| 10 | 2014 | 73 | |
| 11 | 2020 | 72 | |
| 12 | 2008 | 56 | |
| 13 | 2011 | 56 | |
| 14 | 2014 | 54 | |
| 15 | 2010 | 53 | |
| 16 | 2012 | 48 | |
| 17 | 2008 | 47 | |
| 18 | 2021 | 36 | |
| 19 | 2002 | 35 | |
| 20 | 2013 | 35 |
About Frank Andersohn
Frank Andersohn is a scholar working on Genetics, Surgery, General Health Professions, Epidemiology and Hematology, having authored 61 papers that have together received 2.8k indexed citations. Recurring topics across this work include Blood disorders and treatments (6 papers), Health and Medical Studies (5 papers), Health Systems, Economic Evaluations, Quality of Life (4 papers), Substance Abuse Treatment and Outcomes (3 papers), Platelet Disorders and Treatments (3 papers), Atrial Fibrillation Management and Outcomes (3 papers), Drug-Induced Hepatotoxicity and Protection (3 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (418 citations), Toxicology (73 citations), Pharmacology (322 citations), Psychiatry and Mental health (251 citations) and Neurology (209 citations). Frank Andersohn has collaborated with scholars based in Germany, United States and Canada. Frequent co-authors include Edeltraut Garbe, Samy Suissa, R Schade, Wilhelm Haverkamp, Jochen Walker, Elisabeth Bronder, Andreas Klimpel, Stefan N. Willich, Michael Thomae and Niklas Schmedt. Their work appears in journals such as European Journal of Clinical Pharmacology, Pharmacoepidemiology and Drug Safety, Annals of Internal Medicine, American Journal of Psychiatry and Clinical Research in Cardiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.